Department of Internal Medicine, College of Medicine, Dong-A University Medical School, Busan, Korea.
Kidney Res Clin Pract. 2014 Sep;33(3):144-9. doi: 10.1016/j.krcp.2014.05.030. Epub 2014 Jul 23.
Catheter-related exit site infection is a major risk factor for the development of peritonitis and can contribute to failure of treatment maintenance in peritoneal dialysis (PD) patients. Although povidone-iodine can be used for exit site care, the irritation induced by the local application of povidone-iodine could lead to secondary infection. Therefore, we evaluated the clinical effectiveness of normal saline compared with povidone-iodine as a method of exit site care in chronic PD patients.
In all, 126 patients undergoing PD treatment for>6 months between January 2006 and December 2009 were enrolled. Data were retrospectively analyzed for the incidence of exit site infection and peritonitis for 2 years prior to and after December 2007. In addition, we identified the incidences of catheter-related infections during follow-ups from January 2010 to December 2013.
The participants׳ mean age was 58.8±12.9 years. The incidences of exit site infection and peritonitis were one episode per 64.6 patients-months and one episode per 40.4 patients-months in the povidone-iodine group, respectively, whereas these were one episode per 57.5 patients-months and one episode per 45.6 patients-months in the normal saline group, respectively. Whereas Gram-positive bacteria most frequently caused catheter-related infections in both groups, culture-negative infections were dominant in the normal saline group.
Exit site care using normal saline did not increase the incidence of exit site infection and peritonitis. Therefore, normal saline may be an alternative treatment for exit site care in patients receiving PD.
导管相关出口部位感染是发生腹膜炎的一个主要危险因素,并且可能导致腹膜透析(PD)患者治疗失败。虽然聚维酮碘可用于出口部位护理,但聚维酮碘局部应用引起的刺激可能导致继发感染。因此,我们评估了生理盐水与聚维酮碘相比作为慢性 PD 患者出口部位护理方法的临床效果。
共纳入了 126 例在 2006 年 1 月至 2009 年 12 月期间接受 PD 治疗>6 个月的患者。回顾性分析了 2007 年 12 月前和后 2 年的出口部位感染和腹膜炎的发生率。此外,我们还确定了从 2010 年 1 月至 2013 年 12 月随访期间导管相关性感染的发生率。
参与者的平均年龄为 58.8±12.9 岁。聚维酮碘组的出口部位感染和腹膜炎发生率分别为每 64.6 个患者-月发生 1 次和每 40.4 个患者-月发生 1 次,而生理盐水组的发生率分别为每 57.5 个患者-月发生 1 次和每 45.6 个患者-月发生 1 次。虽然两组中革兰阳性菌最常引起导管相关性感染,但在生理盐水组中以培养阴性感染为主。
使用生理盐水进行出口部位护理不会增加出口部位感染和腹膜炎的发生率。因此,生理盐水可能是 PD 患者出口部位护理的替代治疗方法。